Holen Sie sich die Stockscreener-App
1.595
3.33%
-0.055
Schlusskurs vom Vortag:
$1.65
Offen:
$1.66
24-Stunden-Volumen:
142.66K
Relative Volume:
0.55
Marktkapitalisierung:
$85.67M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-1.8988
EPS:
-0.84
Netto-Cashflow:
$-18.45M
1W Leistung:
-10.89%
1M Leistung:
-3.33%
6M Leistung:
+50.47%
1J Leistung:
+3.57%
1-Tages-Spanne:
$1.57
$1.6729
1-Wochen-Bereich:
$1.57
$1.79
52-Wochen-Spanne:
$0.7203
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Firmenname
Quince Therapeutics Inc
Sektor
Branche
Telefon
415-910-5717
Adresse
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Vergleichen Sie QNCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.595 | 88.63M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.41 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.28 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.39 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.96 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.19 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Eingeleitet | Oppenheimer | Outperform |
Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten
Sentiment analysis tools applied to Quince Therapeutics Inc.Trade Ideas & Verified Stock Trade Ideas - newser.com
Is Quince Therapeutics Inc. stock positioned for digital transformationQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Is Quince Therapeutics Inc. stock oversold or undervaluedWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Will earnings trigger a reversal in Quince Therapeutics Inc.2025 Biggest Moves & Verified Entry Point Signals - newser.com
Why retail investors favor Quince Therapeutics Inc. stockTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
What indicators show strength in Quince Therapeutics Inc.July 2025 Catalysts & Advanced Technical Signal Analysis - newser.com
How Quince Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Macro Moves & Community Verified Swing Trade Signals - newser.com
How to forecast Quince Therapeutics Inc. trends using time series2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Statistical indicators supporting Quince Therapeutics Inc.’s strengthQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Quince Therapeutics Inc. stock volume spike explainedPortfolio Profit Report & Smart Allocation Stock Tips - newser.com
Will Quince Therapeutics Inc. stock recover faster than peers2025 Market WrapUp & Community Trade Idea Sharing - newser.com
Can Quince Therapeutics Inc. stock double in next 5 yearsIPO Watch & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockQuarterly Growth Report & Free Reliable Trade Execution Plans - newser.com
How analysts rate Quince Therapeutics Inc. stock todayJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - newser.com
Is Quince Therapeutics Inc. stock cheap compared to fundamentalsWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Combining machine learning predictions for Quince Therapeutics Inc.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Is Quince Therapeutics Inc. showing signs of accumulationPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is Quince Therapeutics Inc. stock ready for a breakoutMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Market reaction to Quince Therapeutics Inc.’s recent newsEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):